GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Marvel Biosciences Corp (TSXV:MRVL) » Definitions » PB Ratio

Marvel Biosciences (TSXV:MRVL) PB Ratio : (As of Jun. 21, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Marvel Biosciences PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-21), Marvel Biosciences's share price is C$0.11. Marvel Biosciences's Book Value per Share for the quarter that ended in Apr. 2024 was C$-0.07. Hence, Marvel Biosciences's PB Ratio of today is .

The historical rank and industry rank for Marvel Biosciences's PB Ratio or its related term are showing as below:

During the past 4 years, Marvel Biosciences's highest PB Ratio was 30.00. The lowest was 0.00. And the median was 0.00.

TSXV:MRVL's PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.33
* Ranked among companies with meaningful PB Ratio only.

Back to Basics: PB Ratio


Marvel Biosciences PB Ratio Historical Data

The historical data trend for Marvel Biosciences's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Marvel Biosciences PB Ratio Chart

Marvel Biosciences Annual Data
Trend Jul20 Jul21 Jul22 Jul23
PB Ratio
- 3.33 17.00 -

Marvel Biosciences Quarterly Data
Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Marvel Biosciences's PB Ratio

For the Biotechnology subindustry, Marvel Biosciences's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Marvel Biosciences's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Marvel Biosciences's PB Ratio distribution charts can be found below:

* The bar in red indicates where Marvel Biosciences's PB Ratio falls into.



Marvel Biosciences PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Marvel Biosciences's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Apr. 2024)
=0.11/-0.069
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Marvel Biosciences  (TSXV:MRVL) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Marvel Biosciences PB Ratio Related Terms

Thank you for viewing the detailed overview of Marvel Biosciences's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Marvel Biosciences (TSXV:MRVL) Business Description

Traded in Other Exchanges
Address
505 - 8th Avenue SW, Suite 420, Calgary, AB, CAN, T2P1G2
Marvel Biosciences Corp is a life sciences company focused on the discovery and development of a synthetic derivative compound of a known drug. It has developed several new chemical entities, using synthetic chemical derivatives of known, off-patent drugs, that inhibit the A2a adenosine receptor with application to neurological diseases (depression & anxiety, Alzheimer's, ADHD), and the non-neurological conditions of cancer and non-alcoholic steatohepatitis. Marvel is also exploring additional undisclosed targets to expand its asset pipeline.
Executives
Joseph Roderick Matheson Director, Senior Officer